CP-LC-1401 860808 2-butyloctyl 3-((4-((2-(dimethylamino)ethyl)amino)-3-(2-octyldodecanamido)-4-oxobutyl)thio)propanoate

Manufactured and Distributed under License from Certest Biotec S.L

CP-LC-1401 is an ionizable lipid that successfully encapsulates mRNA and CRISPR/Cas9. In vivo studies carried out in mice show that lipid nanoparticle (LNP) formulations using ionizable lipid CP-LC-1401 exhibit increased mRNA expression and improved delivery of CRISPR/Cas9 compared to industry leading formulations. LNP formulations using CP-LC-1401 also show favorable safety profiles and improved biodegradability compared to industry leading formulations. LNPs formulated with CP-LC-1401 have shown a primary biodistribution in the liver and exhibit high endosomal escape.